{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:14:30Z","timestamp":1787062470418,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016398","name":"Minist\u00e8re des Arm\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["UMO-2021\/41\/B\/NZ7\/02825"],"award-info":[{"award-number":["UMO-2021\/41\/B\/NZ7\/02825"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["UMO- 2016\/21\/B\/NZ7\/01744"],"award-info":[{"award-number":["UMO- 2016\/21\/B\/NZ7\/01744"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["20181022"],"award-info":[{"award-number":["20181022"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA15135"],"award-info":[{"award-number":["CA15135"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006021","name":"Direction G\u00e9n\u00e9rale de l\u2019Armement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmech.2023.115135","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:47:16Z","timestamp":1674038836000},"page":"115135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies"],"prefix":"10.1016","volume":"249","author":[{"given":"Dawid","family":"Panek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pasieka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gniewomir","family":"Latacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Zar\u0119ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Szcz\u0119ch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Gody\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Chantegreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Brazzolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Skrzypczak-Wiercioch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Smolik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Sa\u0142at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"H\u00f6fner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wi\u0119ckowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Malawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115135_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejmech.2023.115135_bib2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejmech.2023.115135_bib3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2023.115135_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/FBP.0000000000000300","article-title":"A second wind for the cholinergic system in Alzheimer's therapy","volume":"28","author":"Douchamps","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115135_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2012.12.054","article-title":"Butyrylcholinesterase and the cholinergic system","volume":"234","author":"Reid","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2023.115135_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4615-3432-7_2","article-title":"Cholinomimetic replacement of cholinergic function in alzheimer disease","author":"Giacobini","year":"1992","journal-title":"Treat. Dementias ."},{"key":"10.1016\/j.ejmech.2023.115135_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115135_bib8","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.115135_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2023.115135_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbr.2015.08.026","article-title":"Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse","volume":"296","author":"Maurice","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2023.115135_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2006.04347.x","article-title":"Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity","volume":"100","author":"Hartmann","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2023.115135_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00002512-200118120-00001","article-title":"Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?","volume":"18","author":"Giacobini","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejmech.2023.115135_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2023.115135_bib14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.107.133330","article-title":"The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency","volume":"324","author":"Li","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2023.115135_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Ko\u0161ak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115135_bib16","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an alzheimer's disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115135_bib17","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1021\/acs.jmedchem.0c01129","article-title":"Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115135_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010040","article-title":"Alzheimer's disease pharmacotherapy in relation to cholinergic system involvement","volume":"10","author":"Stanciu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2023.115135_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer's disease","volume":"17","author":"Ju","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2023.115135_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2019.02.012","article-title":"Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase","volume":"167","author":"AlFadly","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115135_bib21","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/jm980459s","article-title":"Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease","volume":"42","author":"Yu","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115135_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13543776.2018.1476494","article-title":"A patent review of butyrylcholinesterase inhibitors and reactivators 2010\u20132017","volume":"28","author":"Andrisano","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2023.115135_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00002512-200118120-00001","article-title":"Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?","volume":"18","author":"Giacobini","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejmech.2023.115135_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1185\/03007990152673800","article-title":"A new therapeutic target in Alzheimer's disease treatment: attention to butyryloholinesterase","volume":"17","author":"Greig","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2023.115135_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1358\/dot.2022.58.10.3422314","article-title":"Aducanumab for the treatment of Alzheimer's disease","volume":"58","author":"Tagliapietra","year":"2022","journal-title":"Drugs Today"},{"key":"10.1016\/j.ejmech.2023.115135_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ejmech.2023.115135_bib27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acschemneuro.7b00461","article-title":"Design, synthesis, and biological evaluation of 1-Benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-alzheimer\u2019s agents","volume":"9","author":"Panek","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115135_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113397","article-title":"Discovery of multifunctional anti-Alzheimer\u2019s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and \u03b3-aminobutyric acid transporters","volume":"218","author":"Pasieka","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115135_bib29","first-page":"1c00235","article-title":"Dual inhibitors of amyloid-\u03b2 and tau aggregation with amyloid-\u03b2 disaggregating properties: extended in cellulo , in silico , and kinetic studies of multifunctional anti-alzheimer\u2019s agents","author":"Pasieka","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115135_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(86)90176-4","article-title":"Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions","volume":"156","author":"Staros","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2023.115135_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/cr50028a006","article-title":"Mechanisms of epoxide reactions","volume":"59","author":"Parker","year":"1959","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115135_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2023.115135_bib33","article-title":"Pre-clinical evaluation of cognition enhancing drugs","volume":"13","author":"Schindler","year":"1989","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2023.115135_bib34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.lfs.2010.09.004","article-title":"Assessment of spatial memory in mice","volume":"87","author":"Sharma","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2023.115135_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2016.10.019","article-title":"Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties","volume":"113","author":"Sa\u0142at","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2023.115135_bib36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pharep.2015.04.018","article-title":"The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice","volume":"67","author":"Sa\u0142at","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2023.115135_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cognit. Process."},{"key":"10.1016\/j.ejmech.2023.115135_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2014.08.002","article-title":"Assessing rodent hippocampal involvement in the novel object recognition task. A review","volume":"285","author":"Cohen","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2023.115135_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115135_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2005.06.053","article-title":"Novel parent structures for inhibitors of the murine GABA transporters mGAT3 and mGAT4","volume":"519","author":"Kragler","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115135_bib41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.0014-2956.2001.02692.x","article-title":"Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization","volume":"269","author":"Nachon","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2023.115135_bib42","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","article-title":"Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure","volume":"279","author":"Brazzolotto","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2023.115135_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"XDS, Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115135_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115135_bib45","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115135_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115135_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20143420","article-title":"The 1,3,5-triazine derivatives as innovative chemical family of 5-HT6 serotonin receptor agents with therapeutic perspectives for cognitive impairment","volume":"20","author":"Latacz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115135_bib48","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/molecules24244472","article-title":"Are the hydantoin-1,3,5-triazine 5-HT6R ligands a hope to a find new procognitive and anti-obesity drug? Considerations based on primary in vivo assays and ADME-tox profile in vitro","volume":"24","author":"Lubelska","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115135_bib49","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1039\/C8MD00313K","article-title":"Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1H-imidazole-5-yl)-1H-indole-5-carboxamides, low-basicity 5-HT7 receptor agonists","volume":"9","author":"Latacz","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2023.115135_bib50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pharep.2015.04.018","article-title":"The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice","volume":"67","author":"Sa\u0142at","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2023.115135_bib51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-011-2171-1","article-title":"A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment","volume":"215","author":"Klinkenberg","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2023.115135_bib52","first-page":"47","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data, Behav","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2023.115135_bib53","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat. Protoc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:04:43Z","timestamp":1777529083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":53,"alternative-id":["S0223523423000508"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115135","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115135"}}